Bibliography
- GEORGOPAPADAKOU NH, WALSH TJ: Human mycoses: drugs and targets for emerging pathogens. Science (1994) 264:371–373.
- CID VJ, DURAN A, DEL REY F etal.: Mole cular basis of cell integrity and morphogenes is in Saccharomyces cere-visiae. Microbiol. Rev. (1995) 59:345–386.
- GEORGOPAPADAKOU NH: Antifungals targeted to the cell wall. In: Emerging Drugs: the Prospect for ImprovedMedicines. Bowman WC, Fitzgerald JD, Taylor JB (Eds.), Ashley Publications Ltd., London (1996):261–276. review of cell-wall targeted drugs in development; the present article is an update.
- CURRENT WL, TANG J, BOYLAN C et al: Glucan biosyn-thesis as a target for antifungals: the echinocandin class of antifungal agents. In: Antifungal Agents: Discovery and Mode of Action. Dixon GK, Copping LG, Hollomon DW (Eds.), Bios Scientific Publishers, Oxford (1995):143–160.
- 36th Interscience Conference on Antimicrobial Agents and
- •Chemotherapy. ASM Publications, Washington DC (1996):107–108. Abstract F45-F50. most recent update on the clinical development candidate LY 303366.
- ABRUZZO GK, FLATTERY AM, GILL CJ eta': Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimi-crob. Agents Chemother. (1995) 39:1077–1081.
- 36th Interscience Conference on Antimicrobial Agents and
- •Chemotherapy ASM Publications, Washington DC (1996):104-107. Abstract F27-F44. most recent update on the clinical development candidate L-743,872.